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for the Three-Prefecture Cohort Study Group
Abstract
The incidence of breast cancer among Japanese women is substantially increasing. This study evaluated the effects of reproductive
and lifestyle factors with respect to breast cancer overall and separately among pre- and postmenopausal women using data from
the Three-Prefecture Cohort Study of Japan.
A total of 33,410 women aged 40 to 79 years completed a self-administered questionnaire, which included items about menstrual
and reproductive history and other lifestyle factors. The follow-up period was from 1984 to 1992 in Miyagi and 1985 to 2000 in Aichi
Prefectures. We used Cox proportional hazards regression models to estimate hazards ratios (HRs) and 95% confidence intervals
(CIs) after adjusting for confounding factors.
After 9.8 mean years of follow-up, 287 cases of breast cancer were recorded. In the overall analysis, later menarche (≥16 years)
and parity were significantly associated with a decreased risk of breast cancer, with HRs of 0.69 (95% CI 0.48–0.99) and 0.72 (95%
CI 0.52–0.99), respectively. Further, there was a significant decline in the risk of breast cancer with increasing number of birth among
parous women (P for trend= .010). On the contrary, a family history of breast cancer in themother was significantly associatedwith an
increased risk of breast cancer (HR 3.22, 95%CI 1.52–6.84). Analyses based onmenopausal status at baseline indicated that height
(≥160cm) and weight (≥65kg) were significantly associated with an increased risk of postmenopausal breast cancer, with HRs of
1.34 (95% CI 0.72–2.50) and 3.13 (95% CI 1.75–5.60), respectively. Risk associated with BMI significantly differs by menopausal
status.
Our findings suggest the important role of reproductive factors in the development of breast cancer in Japanese women; however,
body mass index (BMI) may have different effects on breast cancer in Japanese women compared with western women.
Abbreviations: BMI = body mass index, CI = confidence interval, HR = hazard ratio, ICD = International Classification of Disease,
IGF-1 = insulin-like growth factor, RR = relative risk.
Keywords: body mass index, breast cancer, cohort, epidemiology, reproductive factors
1. Introduction
Breast cancer is the most common cancer among women
worldwide, accounting for 25% of all cancer cases among
women.[1] Although Japanese women have a relatively low risk of
breast cancer compared with women in Western countries,[2] the
incidence rate has been increasing rapidly,[3] and breast cancer is
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currently the leading cancer among Japanese women. The
incidence rate of breast cancer among Japanese women increases
with increasing age but decreases or flattens after 50 years of age,
whereas it increases irrespective of age among women inWestern
countries.[4]
A number of epidemiological studies from Western countries
with high incidence rates of breast cancer have been reported.
Early age at menarche, null parity, later age at menopause, late
age at first birth, less experience of breastfeeding, and family
history of breast cancer were important risk factors for the
development of breast cancer.[5–9] A meta-analysis of 8 case–
control studies conducted from 1948 to 1993 in Japan revealed
that reproductive factors for breast cancer risk were similar to
those in Western countries.[10] However, different effects of body
mass index (BMI) on breast cancer have been observed between
women in Japan andWestern countries.[11] For Japanese women,
higher BMI was associated with an increased risk of breast cancer
in both pre- and postmenopausal women.[12] In contrast, higher
BMI in Western countries was associated with an increased risk
of breast cancer in postmenopausal women and a decreased risk
in premenopausal women.[13]
Lifestyle and reproductive patterns have changed among
women in Japan. Although several Japanese cohort studies
examined the association between known and suspected risk
factors and breast cancer incidence,[14–16] a large-scale, popula-
tion-based prospective survey (The Three-Prefecture Cohort
Study)[17] enabled us to provide further evidence for the
association between several risk factors and the risk of breast
cancer among Japanese women. Using this dataset, we evaluated
the effects of reproductive and lifestyle factors related to breast
cancer to investigate differences in these associations between
women in Japan and Western countries.
2. Methods
2.1. Study cohort
The present study was based on the Three-Prefecture Cohort Study,
and its studydesignwaspreviously reported indetail.[17] Briefly, a self-
administered questionnaire regarding demographic factors and
lifestyle characteristics was administered to participants living in
Miyagi, Aichi, andOsaka Prefectures. This study did not include data
from residents in Osaka Prefecture because information on
reproductive factorswas lacking.Of 35,136women, 9were excluded
after the beginning date of follow-up was unified. In addition, 1411
elderly women aged ≥80 years and 306 women with cancer history
were excluded. Finally, 33,410 women aged ≥40 years and without
histories of cancer were eligible for our analyses (Fig. 1).
2.2. Baseline questionnaire survey
The Three-Prefecture Cohort Study conducted baseline question-
naire surveys from February 1, 1983 to November 1, 1985.[17] A
self-administered questionnaire in a sealed envelope was distribut-
ed by hand to participants. The questionnaire covered personal
information as follows: area of residence, sex, height, weight,
frequency of food intake, smoking, alcohol drinking status, family
history of breast cancer in mother, age at menarche, menopausal
status at baseline, age atmenopause, parity history, parity number,
and age at first birth. The agreement or permission of baseline
survey for municipality residents was obtained from the municipal
government with collaborators. The response to the questionnaire
by participant was thought to be the agreement to the survey. The
study was approved by the institutional review board of the
National Cancer Center and the Ethics Committee of Osaka
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Figure 1. Participants from the Three-Prefecture Cohort study who were included in the current analysis.
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2.3. Follow-up and identification of cancer cases
The study participants were followed from the start of the
study, and the follow-up periods of cancer incidence were 9 years
for Miyagi Prefecture (1984–1992) and 15 years for Aichi
Prefecture (1985–2000). Vital status and dates of death and
relocation were confirmed by the local government using
residence certificates. During the study period, 7427 (22.2%)
women moved out of the study area and 3201 (9.6%) died.
Cancer incidence data were collected only for participants living
in the study area. Cancer incidence and the date of diagnosis were
obtained from local population-based cancer registries. The
endpoint of this analysis was the incidence of breast cancer,
defined as the International Classification of Disease 9th version
(ICD9) codes 174 to 175.9 and 10th version (ICD10), codes C50
to C50.9. Up to the end of the cancer incidence follow-up period,
287 new breast cancer cases were identified in this population
(Fig. 1).
2.4. Statistical analysis
The person-years of follow-up were calculated from the baseline
survey for each participants until the date of diagnosis of breast
cancer, or the date of emigration from the study area, or the date
of death, or the end of follow-up (Miyagi, December 31, 1992;
Aichi, December 31, 2000). The exposure variables analyzed in
the present study were age at menarche, menopausal status, age
at menopause, parity history, parity number, age at first birth,
and family history of breast cancer in the mother. The crude
incidence rate per 100,000 for breast cancer was calculated by
dividing the number of breast cancer cases by the number of
person-years. The Cox proportional hazards model was used to
estimate hazard ratios (HRs) and 95% confidence intervals (CIs)
of breast cancer incidence by the exposure variables using STATA
version 13 MP (Stata Corp., College Station, TX).
The following variables were used for adjustment as potential
confounders: age, area, region (urban/rural), BMI, alcohol
consumption, smoking status, green-yellow vegetables consump-
tion, other vegetables consumption, packed vegetables consump-
tion, fruit consumption, miso soup consumption. Different sets of
exposure variables were used for adjustment in respective
estimated models (see footnotes in Tables 1–3). In our analyses,
missing values in confounders were treated as an additional
category and included in the models. Linear trends were assessed
using the Cox proportional hazards models by treating each
exposure category as a continuous variable. In the subgroup
analyses, we excluded women without menopausal information
at baseline. According to menopausal status (pre or post), we
assessed breast cancer risk by reproductive factors and other
variables, including height (<148, 148–151, 152–155, 156–159,
or ≥160cm), weight (<50, 50–54, 55–59, 60–64, or ≥65kg),
BMI (<18.5, 18.5–24.9, 25.0–26.9, or ≥27.0kg/m2), smoking
category (never, former, or current), and drinking category
(never, former, sometimes, or almost daily). In addition,
chi-square tests were used to determine differences the distribu-
tions of categorical variables of the baseline characteristics. All
P values reported are 2-sided, and the significance level was set at
P< .05.
3. Results
The demographic and lifestyle characteristics of the study
participants at baseline with respect to menopausal status are
presented in Table 1. Among the 33,410 participants, 10,861
(32.5%) were premenopausal and 20,831 (62.4%) were
postmenopausal; the menopausal status was undefined in 1718
participants (5.1%). Compared with postmenopausal women,
premenopausal women tended to be taller and thinner. Most of
women were never smokers, and approximately half of women
had never consumed alcohol.
Table 2 shows the reproductive characteristics of participants
at baseline by menopausal status. The proportions of those aged
13 years at menarchewas 31.8% in premenopausal women and
18.5% in postmenopausal women. The proportion of postmen-
opausal women with no parous experience (11.7%) was higher
than that among premenopausal women (8.3%). Among parous
Table 1








Number of participants 33,410 10,861 20,831
Area (%)
Miyagi Prefecture 48.9 46.2 49.5 <.001
Aichi Prefecture 51.1 53.8 50.5
Region (%)
Rural 40.5 38.4 40.3 .001
Urban 59.5 61.6 59.7
Age group (%)
40–49 32.2 81.6 8.0 <.001
50–59 31.8 14.2 41.7
60–69 22.7 2.7 32.5
70–79 13.3 1.5 17.9
Height (%)
<148 16.0 8.2 19.7 <.001
148–151 29.4 25.5 31.9
152–155 25.8 29.8 24.4
156–159 15.3 20.8 12.9
160+ 9.0 13.9 6.7
Missing 4.5 1.8 4.4
Weight (%)
<50 35.1 30.9 37.2 <.001
50–54 25.7 28.8 24.7
55–59 18.1 19.7 17.7
60–64 11.0 11.4 11.0
65+ 7.2 7.6 6.9
Missing 2.9 1.6 2.5
Body mass index (%)
<18.5 7.7 5.9 8.6 <.001
18.5–24.9 66.8 73.9 64.7
25.0–26.9 11.4 10.7 11.8
≥27.0 9.0 7.3 9.9
Missing 5.1 2.31 5.0
Smoking status (%)
Never 66.2 71.4 65.9 <.001
Former 3.0 2.0 3.6
Current 9.0 8.5 9.5
Missing 21.8 18.1 21.1
Drinking status (%)
Never 44.8 41.0 48.4 <.001
Former 2.2 1.7 2.6
Sometimes 24.9 33.6 21.3
Almost daily 5.1 6.1 4.8
Missing 23.0 17.7 23.0
Excluding 1718 women without information on menopausal status at baseline.
∗
Chi-square test for categorical variables.
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women, only 7.0% had 1 child no matter the menopause status.
In addition, the proportion of women who had a first birth
younger than 21 years was higher among postmenopausal
women (19.6%) than that among premenopausal women
(9.7%). Only 0.8% of women overall had a family history of
breast cancer.
Of 325,840 person-years for 33,410 study participants
(average follow-up period: 9.8 years), 94, 183, and 10 cases of
breast cancer were recorded among premenopausal, postmeno-
pausal, and undefined women at baseline, respectively. The HRs
and 95% CIs of breast cancer according to menstrual and
reproductive factors among the women overall are shown in
Table 3. Compared with women with earlier menarche (13
years), women with later age at menarche (≥16 years) had a
significant risk reduction of breast cancer incidence (HR 0.69;
95% CI 0.48–0.99). Relative to nulliparous women, the multi-
adjusted HR for parous women was 0.72 (95% CI 0.52–0.99).
Among parous women, the risk decreased significantly with an
increasing number of births (P for trend= .010), even after
adjusting for age at first birth. The risk of breast cancer incidence
was significantly reduced for women with ≥5 births relative to
those with 1 birth (HR 0.43; 95% CI 0.19–0.97). Women whose
mother had a history of breast cancer had a significantly
increased risk of breast cancer (HR 3.22; 95% CI 1.52–6.84).
After excluding 1718 women whose information of meno-
pausal status were missing at baseline, the HRs of breast cancer
bymenopausal status were showed in Table 4. Comparedwith an
age of 13 at menarche, the risk of breast cancer incidence
decreased marginally for those ≥16 years in postmenopausal
women (HR 0.66; 95%CI 0.43–1.02).Womenwith a later age at
menopause (≥54 years) had a higher risk of breast cancer (HR
1.72; 95% CI 0.98–3.02) compared with those with age at
menopause 47 years. Regardless of the menopausal status, the
risk of breast cancer incidence was significantly reduced for
parous women (HR 0.54; 95% CI 0.30–0.99 among premeno-
pausal women and HR 0.64; 95% CI 0.43–0.94 among
postmenopausal women). Although the risk of breast cancer
incidence among parous women decreased with increasing
number of births in both pre- and postmenopausal women,
only the risk for premenopausal women was statistically
significant (P for trend= .010). Women whose mother had
breast cancer had increased risks for the disease, although a
significant association was observed only among postmenopaus-
al women (HR: 4.49; 95% CI 1.83–11.00).
Table 5 shows the HRs of breast cancer incidence by height,
weight, BMI, smoking status, and drinking category according to
menopausal status. Overall, a positive association between height
and breast cancer risk was observed for both pre- and
postmenopausal women (P for trend= .340 and .009, respective-
ly). Weight was also associated with an increased risk of breast
cancer in both pre- and postmenopausal women, but the
association was more evident in postmenopausal women (P
for trend< .001). Among postmenopausal women, a high BMI
was associated with high HRs of breast cancer incidence
compared with that in women with a low BMI (P for
trend= .002), while it was not associated in premenopausal
women with breast cancer. In contrast, smoking and drinking
category were not associated with the risk of breast cancer
incidence irrespective of the menopausal status.
4. Discussion
This population-based prospective cohort study from 3 pre-
fectures in Japan demonstrated that several menstrual and
reproductive factors; family history of breast cancer in the
mother; height; weight; and high BMI were associated with an
increased risk of breast cancer.
Estrogen plays an important role in the development of breast
cancer.[18] Women who start menstruating early in life have an
increased risk of developing breast cancer.[19] Early menarche
was associated with the early onset and increased frequency of
ovulatory circles. Women with an early age of menarche are
earlier exposed to increased ovarian hormone levels and have
higher estrogen levels for several years longer. Several years of
exposure to high-level estrogen stimulus increased the risk of
breast cancer.[20,21] In other words, an older age of menarche is
associated with a lower risk of breast cancer. For every year delay
in menarche, the risk decreases by around 5%.[22] In the present
study, a risk decrement was observed among women with later
age at menarche (women aged ≥16 years, HR, 0.69; 95% CI
0.48–0.99) and the risk decreased nearly 6% for each 1-year
delay in menarche (data not shown).
Pregnancy promotes the differentiation of mammary gland
epithelium, and the differentiated cells are not susceptible to
undergo neoplastic transformation. Therefore, when the early
first full pregnancy occurs early, the early differentiation of
Table 2







Age at menarche (%)
13 22.1 31.8 18.5 <.001
14 20.9 27.8 18.7
15 21.1 21.4 22.0
≥16 28.7 16.5 36.2
Missing 7.3 2.5 4.5







Nulliparous 11.6 8.3 11.7 <.001
Parous 86.8 91.5 87.8
Missing 1.6 0.2 0.6
Number of births (%) n=28,986
1 7.0 7.0 7.0 <.001
2 24.2 34.1 19.2
3 17.7 17.8 17.6
4 7.8 3.8 9.9
≥5 10.1 2.3 13.3
Missing 33.2 35.0 33.0
Age at 1st-birth (%) n=28,986
21 16.3 9.7 19.6 <.001
22–25 50.2 52.1 49.5
26–29 22.9 27.6 20.7
≥30 8.1 8.2 8.1
Missing 2.5 2.4 2.2
Family history of breast cancer in mother (%)
Other 99.2 98.9 99.3
Yes 0.8 1.1 0.7 <.001
Excluding 1718 women without information on menopausal status at baseline.
∗
Chi-square test for categorical variables.
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mammary gland cells are induced.[23] In addition, the first full
pregnancy changes the long-term hormonal levels including
decreased prolactin, higher sex hormone-binding globulin, and
lower estrogen, which may be associated with the decreased of
breast cancer.[16] Compared with nulliparous women, women
who have had at least one full-term pregnancy have an
approximately 25% reduction in breast cancer risk.[6,7] In
addition, a younger age at first birth was associated with greater
protection against breast cancer.[22,24] A previous study showed
that women with first delivery after 35 years of age had a risk
about 40% higher than that in those with a first birth before 20
years.[7] In addition, women with multi-parity had a lower risk of
breast cancer than that in women with low parity. The risk of
breast cancer significantly declined with increasing number of
birth even after controlling for the influence of various risk
factors related to breast cancer. Our result was similar to one
from other previous studies[5–10,14,16] and would reinforce the
importance of the association between high parity and the
decreased risk of breast cancer. In addition, this phenomenon
would be partially explained by the long-lasting protective effect
which has been enhanced by every new full-term pregnancy after
the first. The diminution in breast cancer risk with increasing
parity may be related to changes in plasma prolactin levels, and
high parity was associated with low prolactin concentration both
in pre- and postmenopausal women.[22] Our results were similar
to those of other studies in which parous women had a 28%
reduction in breast cancer risk relative to nulliparous women.
Women with >5 children had exceedingly lower risks than those
of womenwith only 1 child. Furthermore, womenwith a later age
at first birth tended to have a higher risk of breast cancer,
although the results were not statistically significant.
The results of this study underscored that women with a
family history of breast cancer were at an increased risk of the
disease, which could be explained partially by shared genes.
Mutations in BRCA1, BRCA2, P53, PTEN, and ATM are
associated with breast cancer risk, especially those in BRCA1 and
BRCA2.[22]BRCA2 plays a more important role than BRCA1 in
Japanese familial breast cancers.[25,26] The pooled estimate of
Table 3
HR of breast cancer incidence according to reproductive factors.
No. of cases Person-years Incidence rate per 100,000
Age and area-adjusted Multivariable-adjusted
HR1 (95% CI) P for trend HR2 (95% CI) P for trend
Menopausal status
Premenopausal women 94 107221 87.7 1.00 1.00
∗
Postmenopausal women 183 202877 90.2 0.95 (0.68–1.32) 0.92 (0.66–1.29)
Age at menarche
13 75 73925 101.5 1.00 .010 1.00† .136
14 57 69044 82.6 0.79 (0.56–1.12) 0.84 (0.59–1.18)
15 71 68959 103.0 0.96 (0.69–1.33) 1.06 (0.76–1.47)
≥16 59 91023 64.8 0.58 (0.41–0.83) 0.69 (0.48–0.99)
Parity
Nulliparous 47 38122 123.3 1.00 1.00‡
Parous 239 283679 84.3 0.67 (0.49–0.91) 0.72 (0.52–0.99)
No. of birth
1 22 18008 122.2 1.00 .001 1.00x .010
2 57 66708 85.4 0.72 (0.44–1.18) 0.70 (0.42–1.17)
3 33 48581 67.9 0.55 (0.32–0.94) 0.57 (0.33–1.00)
4 9 20724 43.4 0.33 (0.15–0.73) 0.37 (0.16–0.83)
≥5 12 24320 49.3 0.35 (0.17–0.74) 0.43 (0.19–0.97)
Age at first-birth
21 30 44677 67.1 1.00 .008 1.00k .177
22–25 111 144724 76.7 1.17 (0.78–1.76) 1.07 (0.71–1.61)
26–29 67 65507 102.3 1.58 (1.02–2.46) 1.30 (0.83–2.04)
≥30 25 22495 111.1 1.71 (1.00–2.92) 1.27 (0.73–2.21)
Family history of breast cancer in mother (%)
Other 280 323338 86.6 1.00 1.00¶
Yes 7 2503 279.7 3.26 (1.54–6.92) 3.22 (1.52–6.84)
CI= confidence interval; HR=hazard ratio.
HR1: adjusted for age (continuous) and area (Miyagi and Aichi).
HR2: adjusted for age (continuous), area (Miyagi and Aichi), region (urban and rural), BMI (–18.5, 18.5–24.9, 25.0–26.9, 27.0+, missing), drinking (never, former, sometimes, almost daily, missing), smoking
(never, former, current, missing), green-yellow vegetables consumption (1–2 times/mo, 1–2 times/wk, 3–4 times/wk, almost daily, missing), non-green and yellow vegetable consumption (1–2 times/mo, 1–
2 times/wk, 3–4 times/wk, almost daily, missing), fruit (1–2 times/mo, 1–2 times/wk, 3–4 times/wk, almost daily, missing), miso (1–2 times/mo, 1–2 times/wk, 3–4 times/wk, almost daily, missing), packed
vegetables (1–2 times/mo, 1–2 times/wk, 3–4 times/wk, almost daily, missing), and family history of breast cancer in mother (other, yes).
∗
Adjusted for age at menarche (–13, 14, 15, 16+, missing), parity (nulliparous, parous, missing), age at 1st-birth (–21, 22–25, 26–29, 30+, missing) plus HR2.
† Adjusted for menopausal status (premenopausal women, age at menopause for postmenopausal women [–47, 48–50, 51–53, 54+, missing]), parity (nulliparous, parous, missing), age at 1st-birth (–21, 22–
25, 26–29, 30+, missing) plus HR2.
‡ Adjusted for age at menarche (–13, 14, 15, 16+, missing), menopausal status (premenopausal women, age at menopause for postmenopausal women [–47, 48–50, 51–53, 54+, missing]) plus HR2.
x (Parous) adjusted for age at menarche (–13, 14, 15, 16+, missing), menopausal status (premenopausal women, age at menopause for postmenopausal women [–47, 48–50, 51–53, 54+, missing]), age at
1st-birth (–21, 22–25, 26–29, 30+, missing) plus HR2.
k (Parous) adjusted for age at menarche (–13, 14, 15, 16+, missing), menopausal status (premenopausal women, age at menopause for postmenopausal women [–47, 48–50, 51–53, 54+, missing]), no. of
birth (1, 2, 3, 4, 5+, missing) plus HR2.
¶ Adjusted for age at menarche (–13, 14, 15, 16+, missing), menopausal status (premenopausal women, age at menopause for postmenopausal women [–47, 48–50, 51–53, 54+, missing]), parity (nulliparous,
–22, 22–25, 26–29, 30+, missing) plus HR2 but excluding family history of breast cancer in mother.
Liu et al. Medicine (2019) 98:51 www.md-journal.com
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relative risk (RR)ofwomenwitha single affectedfirst-degree relative
(mother, sister, or daughter) was 2.1 (95% CI: 2.0–2.2).[27] In the
present study, the HR of women with a family history of breast
cancer in mother was about 3 times, which was similar to that in
previous study in Japan (HR: 2.79, 95% CI 1.59–4.87).[15]
Obesity increased the risk of breast cancer in postmenopausal
women.[22,27] After menopause, instead of ovarian, aromatiza-
tion of adrenal androgens to estrogens in adipose tissue become
the main estrogen source.[28,29] As BMI increases, estradiol
increases and sex hormone-binding globulin concentration
deceases in postmenopausal women. Therefore, obese postmen-
opausal women have higher levels of bioavailable estrogens,
resulting in increased risks of breast cancer.[30] A meta-analysis
showed that a 5kg/m2 increase in BMI was positively associated
with postmenopausal breast cancer (RR: 1.12, 95% CI 1.08–
1.16).[13] In this study, HR per 5kg/m2 increased of BMI: 1.07
(95%CI: 1.03–1.10) in postmenopausal women (data not shown
in Table).
Circulating insulin-like growth factor (IGF)-1 concentration
was also positively related to the risk of premenopausal breast
cancer. IGF-1 concentration is low among women with low BMI
and increases with increasing BMI but decreases again with
obesity.[31] In addition, obese premenopausal women tend to
have an increased frequency of anovulatory menstrual cycles and
lower estrogen level.[30] These might be associated with an
inverse association between increased BMI and premenopausal
breast cancer. A significant inverse association was observed
among women with BMI ≥31kg/m2.[11] However, a previous
study suggested an inverse association between increased BMI
and premenopausal breast cancer in North American, European,
and Australian but a positive association in Asian women.[13]
Compared with Western women, Japanese women have a low
prevalence of obesity (BMI ≥30kg/m2), at ∼3%,[32] compared
with ∼33% in the United States,[33] and ∼19% in the European
Union.[34] This may be one reason for the lack of inverse
association in Japan.
Table 4
HR of breast cancer incidence according to reproductive factors by menopausal status.
Premenopausal women Postmenopausal women
No. of cases HR (95% CI) P for trend No. of cases HR (95% CI) P for trend
Age at menarche
13 33 1.00∗ .629 42 1.00∗ .148
14 23 0.83 (0.48–1.42) 34 0.85 (0.54–1.35)
15 16 0.77 (0.42–1.43) 53 1.18 (0.78–1.78)
≥16 13 0.93 (0.47–1.85) 45 0.66 (0.43–1.02)
Age at menopause
47 42 1.00† .125
48–50 55 1.18 (0.79–1.77)
51–53 34 1.14 (0.72–1.81)
≥54 18 1.72 (0.98–3.02)
Parity
Nulliparous 13 1.00‡ 32 1.00‡
Parous 81 0.54 (0.30–0.99) 151 0.64 (0.43–0.94)
No. of birth
1 8 1.00x .010 13 1.00x .210
2 30 0.67 (0.29–1.51) 24 0.64 (0.32–1.30)
3 8 0.35 (0.13–0.98) 23 0.70 (0.34–1.44)
4 1 0.20 (0.02–1.71) 7 0.41 (0.16–1.10)
≥5 0 12 0.58 (0.23–1.46)
Age at first-birth
21 4 1.00k .871 25 1.00k .105
22–25 42 1.57 (0.56–4.45) 65 0.95 (0.60–1.52)
26–29 25 1.63 (0.56–4.81) 41 1.34 (0.80–2.24)
≥30 6 1.23 (0.33–4.52) 18 1.40 (0.74–2.64)
Family history of breast cancer in mother
Other 92 1.00¶ 178 1.00¶
Yes 2 2.21 (0.54–9.05) 5 4.49 (1.83–11.00)
Excluding 1718 women without information on menopausal status at baseline.
CI= confidence interval; HR=hazard ratio.
HR: adjusted for age (continuous), area (Miyagi and Aichi), region (urban and rural), BMI (–18.5, 18.5–24.9, 25.0–26.9, 27.0+, missing), drinking (never, former, sometimes, almost daily, missing), smoking
(never, former, current, missing), green-yellow vegetables, non-green and yellow vegetable consumption (1–2 times/mo, 1–2 times/wk, 3–4 times/wk, almost daily, missing), fruit (1–2 times/mo, 1–2 times/
wk, 3–4 times/wk, almost daily, missing) consumption (1–2 times/mo, 1–2 times/wk, 3–4 times/wk, almost daily, missing), miso (1–2 times/mo, 1–2 times/wk, 3–4 times/wk, almost daily, missing), and
packed vegetables (1–2 times/mo, 1–2 times/wk, 3–4 times/wk, almost daily, missing) and family history of breast cancer in mother (other, yes).
∗
Adjusted for parity (nulliparous, parous, missing), age at 1st-birth (–21, 22–25, 26–29, 30+, missing), age at menopause for postmenopausal women (–47, 48–50, 51–53, 54+, missing) plus HR.
† Adjusted for age at menarche (–13, 14, 15, 16+, missing), parity (nulliparous, parous, missing), age at 1st-birth (–21, 22–25, 26–29, 30+, missing) plus HR.
‡ Adjusted for age at menarche (–13, 14, 15, 16+, missing), age at menopause for postmenopausal women (–47, 48–50, 51–53, 54+, missing) plus HR.
x (Parous) adjusted for age at menarche (–13, 14, 15, 16+, missing), age at 1st-birth (–21, 22–25, 26–29, 30+, missing), age at menopause for postmenopausal women (–47, 48–50, 51–53, 54+, missing)
plus HR.
k (Parous) adjusted for age at menarche (–13, 14, 15, 16+, missing), no. of birth (1, 2, 3, 4, 5+, missing), age at menopause for postmenopausal women (–47, 48–50, 51–53, 54+, missing) plus HR.
¶ Adjusted for age at menarche (–13, 14, 15, 16+, missing), age at menopause for postmenopausal women (–47, 48-50, 51–53, 54+, missing)], parity (nulliparous, –22, 22–25, 26–29, 30+, missing) plus HR
but excluding family history of breast cancer in mother.
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The mechanisms underlying the association between height
and breast cancer risk are not completely understood. Height is
primarily determined by genetic factors. However, early energy
and nutrition restriction, resulting in short height, may inhibit cell
proliferation and early events in tumorigenesis.[11] Women in this
study born between 1905 and 1945 might have been experienced
nutritional inadequacy in childhood and adolescence during
World War II, resulting in sufficient variation in energy intake,
which has been proposed as an explanation for the positive
association between height and breast cancer risk.[35] Pooled
analysis of Western countries[11] showed a significant positive
association between height and the risk of postmenopausal breast
cancer, while the association was not significant for premeno-
pausal women. One study from Japan also indicated that the
positive association was more evident in postmenopausal
women.[35]
This study had several limitations. First, the follow-up period
of the cohort study was 1984 to 1992 in Miyagi Prefecture and
1985 to 2000 in Achi Prefecture, and the reproductive and life
style patterns of this study might differ from the present situation
in 2019. Further, we did not have information on menopausal
status after the start of follow-up. In addition, the information on
BMI and other confounders were also based on the baseline
questionnaire; thus, we were unable to consider changes over
time of those confounders. Second, this study obtained
information about family history of breast cancer, however,
since our questionnaire could not differentiate between “no,”
“unknown,” or “missing” responses, we treated these as 1 item.
Therefore, this study likely underestimated the effect of a family
history of breast cancer. Third, reproductive information such as
breastfeeding, and the information on exogenous female
hormone use were lacking. In addition, we could not evaluate
the association of menstrual and reproductive factors with
hormone receptor-defined breast cancer.[17]
In conclusion, in this large-scale prospective cohort study
among Japanese women, we showed that multi-parity was
associated with a decreased risk of breast cancer. Early age at
menarche (13 years) and family history of breast cancer in the
mother were related to an increased risk of breast cancer. Height,
weight, and BMI ≥25.0kg/m2 were also associated with an
increased risk of breast cancer in postmenopausal women.
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Body mass index





25.0–26.9 8 0.88 (0.42–1.84) 34 1.88 (1.28–2.78)
≥27.0 8 1.38 (0.65–2.92) 21 1.50 (0.93–2.41)
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Excluding 1718 women without information on menopausal status at baseline.
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yellow vegetable consumption (1–2 times/mo, 1–2 times/wk, 3–4 times/wk, almost daily, missing), fruit (1–2 times/mo, 1–2 times/wk, 3–4 times/wk, almost daily, missing), miso (1–2 times/mo, 1–2
times/wk, 3–4 times/wk, almost daily, missing), packed vegetables (1–2 times/mo, 1–2 times/wk, 3–4 times/wk, almost daily, missing), family history of breast cancer in mother, age at menarche (–13, 14,
15, 16+, missing), parity (nulliparous, –22, 22–25, 26–29, 30+, missing), and age at menopause for postmenopausal women (–47, 48–50, 51–53, 54+, missing).
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‡ Adjusted for body mass index (–18.5, 18.5–24.9, 25.0+, missing), drinking (never, former, sometimes, almost daily, missing) plus HR.
x Adjusted for body mass index (–18.5, 18.5–24.9, 25.0+, missing), smoking (never, former, current, missing) plus HR.
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